These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 5979032)

  • 21. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis.
    Fortin D; Gendron C; Boudrias M; Garant MP
    Cancer; 2007 Feb; 109(4):751-60. PubMed ID: 17211866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Results of combined treatment of advanced squamous cell carcinoma of the lung with vincristine, adriamycin and cyclophosphamide].
    Krawczyk K; Krochmal M; Pawlicki M; Kulpa J; Zielezińska A
    Pneumonol Pol; 1983 Feb; 51(2):107-11. PubMed ID: 6878054
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of advanced breast cancer with cyclophosphamide, methotrexate, 5-fluorouracil and prednisone (CMFP)].
    Rabinovich MG; Leone BA; Landó O
    Medicina (B Aires); 1981; 41(1):65-70. PubMed ID: 7266359
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of cisplatin, cyclophosphamide, vincristine, and doxorubicin for the treatment of non-small cell lung cancer.
    Lindgren D; Cadman E; Erichson R; Grann V; Sachs K
    Cancer Treat Rep; 1984 Sep; 68(9):1159-61. PubMed ID: 6090015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II study of cyclophosphamide and hexamethylmelamine in non-oat cell bronchogenic carcinoma.
    Pisoni MB; Libretti A; Piazza E; Vago G; Scapaticci R; Bianchi C; Tomirotti M; Scanni A; Calzavara MP; Cassani L; Scarpazza G; Marsoni S; Morasca L
    Cancer Treat Rep; 1981; 65(7-8):731-2. PubMed ID: 6788372
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical trial of fadrozole hydrochloride for postmenopausal patients with recurrent breast cancer].
    Kanzaki M; Nakaya Y; Kojima K; Toda H; Tobayama S; Machida H; Ohba M
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):959-65. PubMed ID: 10396324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adriamycin/cyclophosphamide: current standard in adjuvant therapy for breast carcinoma?].
    Sauter C
    Schweiz Med Wochenschr; 1994 Oct; 124(43):1879-81. PubMed ID: 7973513
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical study of preoperative chemotherapy of primary breast cancer. 1. Efficacy of a combined use of CPA (endoxan) and FT-207 (or 5-FU dry syrup)].
    Komuro K; Hara Y; Fujii Y; Yamazaki M; Amano R; Hashiguchi F; Sakamoto R; Nakamura R; Shimada A; Kurata T; Ando H; Nakamura K
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2180-5. PubMed ID: 6820892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of advanced adenocarcinoma of the lung with ftorafur, doxorubicin, cyclophosphamide, and cisplatin (FACP) and intensive iv hyperalimentation.
    Jordan WM; Valdivieso M; Frankmann C; Gillespie M; Issell BF; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(3-4):197-205. PubMed ID: 6786737
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of non-small cell bronchopulmonary carcinoma with the combination of cyclophosphamide, adriamycin and cisplatin].
    Donnay Candil O; Jiménez Berlana U
    Rev Esp Oncol; 1983; 30(4):603-10. PubMed ID: 6100970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of advanced breast cancer: How much chemotherapy is enough?
    DiPaola RS; Kaufman A; Mikhail MM
    Semin Oncol; 1996 Jun; 23(3):xv-xxii; discussion xxii-xxiv. PubMed ID: 8658211
    [No Abstract]   [Full Text] [Related]  

  • 32. [Radiation and combination treatment of breast cancer metastases to the lungs].
    Nivinskaia MM; Abramova NA; Klykova ID
    Med Radiol (Mosk); 1983 Apr; 28(4):51-5. PubMed ID: 6835072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [High dose cisplatin combination chemotherapy for advanced breast cancer--a report on 50 cases].
    Zhou JC
    Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):215-7. PubMed ID: 8261870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Adriamycin/cyclophosphamide: current standard in the adjuvant therapy of breast carcinoma? Or: how should one really put this question?].
    Cavalli F
    Schweiz Med Wochenschr; 1994 Oct; 124(43):1882-4. PubMed ID: 7973514
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of VP-16-213, cyclophosphamide, doxorubicin, and cisplatin (V-CAP) in advanced large cell lung cancer.
    Eagan RT; Frytak S; Nichols WC; Ingle JN; Creagan ET; Kvols LK; Coles DT
    Cancer Treat Rep; 1981; 65(7-8):715-7. PubMed ID: 6166376
    [No Abstract]   [Full Text] [Related]  

  • 36. [Results of "5-drug" treatment of advanced breast cancer].
    Dorociak R
    Pol Tyg Lek; 1981 Sep; 36(38):1467-70. PubMed ID: 7329862
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of the importance and relevance of dose intensity using epirubicin and cyclophosphamide in metastatic breast cancer: interim analysis of a prospective randomized trial.
    Marschner N; Kreienberg R; Souchon R; Räth U; Eggeling B; Voigtmann R; Ruffert K; Schütte M; Ammon A; Kesztyüs T
    Semin Oncol; 1994 Feb; 21(1 Suppl 1):10-6. PubMed ID: 8153652
    [No Abstract]   [Full Text] [Related]  

  • 38. [Endoxan in palliative treatment of breast cancer].
    Sulocka J; Kobierska A; Solska E
    Wiad Lek; 1972 May; 25(9):821-5. PubMed ID: 4112896
    [No Abstract]   [Full Text] [Related]  

  • 39. [Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer].
    Abe O; Izuo M; Enomoto K; Kubo K; Koyama H; Sakai K; Terasawa T; Tominaga T; Nomura Y
    Gan To Kagaku Ryoho; 1982 May; 9(5):866-73. PubMed ID: 7184431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The use of oral futraful as secondary treatment of patients with metastatic carcinoma].
    Labianca R; Beretta G; Luporini G
    G Ital Chemioter; 1982; 29(1):55-8. PubMed ID: 6821043
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.